Paper23945604
Basic concepts in physiologically based pharmacokinetic modeling in drug discovery and development.
Jones H and 1 other. CPT Pharmacometrics Syst Pharmacol, 2013. Cited by 463 papers, by iCite.
Cite this record
ConductScience Library. Basic concepts in physiologically based pharmacokinetic modeling in drug discovery and development. Papers, record 23945604. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23945604
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Basic concepts in physiologically based pharmacokinetic modeling in drug discovery and development.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References70
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 17981004 | General approach for the calculation of tissue to plasma partition coefficients. | Toxicol In Vitro | 2008 | https://conductscience.org/library/papers/17981004 | PubMed |
| 2 | 10772639 | Dose-dependent pharmacokinetics of cyclosporin A in rats: events in tissues. | Drug Metab Dispos | 2000 | https://conductscience.org/library/papers/10772639 | PubMed |
| 3 | 9773391 | Lumping of whole-body physiologically based pharmacokinetic models. | J Pharmacokinet Biopharm | 1998 | https://conductscience.org/library/papers/9773391 | PubMed |
| 4 | 19199378 | The Simcyp population-based ADME simulator. | Expert Opin Drug Metab Toxicol | 2009 | https://conductscience.org/library/papers/19199378 | PubMed |
| 5 | 11576695 | Predicting the impact of physiological and biochemical processes on oral drug bioavailability. | Adv Drug Deliv Rev | 2001 | https://conductscience.org/library/papers/11576695 | PubMed |
| 6 | 19184451 | Predicting pharmacokinetics of drugs using physiologically based modeling--application to food effects. | AAPS J | 2009 | https://conductscience.org/library/papers/19184451 | PubMed |
| 7 | 15025742 | The CYP2C8 inhibitor trimethoprim increases the plasma concentrations of repaglinide in healthy subjects. | Br J Clin Pharmacol | 2004 | https://conductscience.org/library/papers/15025742 | PubMed |
| 8 | 16176562 | Metabolism of repaglinide by CYP2C8 and CYP3A4 in vitro: effect of fibrates and rifampicin. | Basic Clin Pharmacol Toxicol | 2005 | https://conductscience.org/library/papers/16176562 | PubMed |
| 9 | 20869379 | A unified algorithm for predicting partition coefficients for PBPK modeling of drugs and environmental chemicals. | Toxicol Appl Pharmacol | 2010 | https://conductscience.org/library/papers/20869379 | PubMed |
| 10 | 22143261 | Towards a platform PBPK model to characterize the plasma and tissue disposition of monoclonal antibodies in preclinical species and human. | J Pharmacokinet Pharmacodyn | 2012 | https://conductscience.org/library/papers/22143261 | PubMed |
| 11 | 17428153 | Whole-body physiologically based pharmacokinetic models. | Expert Opin Drug Metab Toxicol | 2007 | https://conductscience.org/library/papers/17428153 | PubMed |
| 12 | 20170207 | A semi-mechanistic model to predict the effects of liver cirrhosis on drug clearance. | Clin Pharmacokinet | 2010 | https://conductscience.org/library/papers/20170207 | PubMed |
| 13 | 16928154 | Prediction of the clearance of eleven drugs and associated variability in neonates, infants and children. | Clin Pharmacokinet | 2006 | https://conductscience.org/library/papers/16928154 | PubMed |
| 14 | 20368326 | Prediction of human intestinal first-pass metabolism of 25 CYP3A substrates from in vitro clearance and permeability data. | Drug Metab Dispos | 2010 | https://conductscience.org/library/papers/20368326 | PubMed |
| 15 | 19455625 | Development of a novel method for predicting human volume of distribution at steady-state of basic drugs and comparative assessment with existing methods. | J Pharm Sci | 2009 | https://conductscience.org/library/papers/19455625 | PubMed |
| 16 | 16520012 | Ionization, lipophilicity and solubility properties of repaglinide. | J Pharm Biomed Anal | 2006 | https://conductscience.org/library/papers/16520012 | PubMed |
| 17 | 22644330 | Physiologically based pharmacokinetics joined with in vitro-in vivo extrapolation of ADME: a marriage under the arch of systems pharmacology. | Clin Pharmacol Ther | 2012 | https://conductscience.org/library/papers/22644330 | PubMed |
| 18 | 23598453 | Systems pharmacology for drug discovery and development: paradigm shift or flash in the pan? | Clin Pharmacol Ther | 2013 | https://conductscience.org/library/papers/23598453 | PubMed |
| 19 | 22228214 | Application of IVIVE and PBPK modeling in prospective prediction of clinical pharmacokinetics: strategy and approach during the drug discovery phase with four case studies. | Biopharm Drug Dispos | 2012 | https://conductscience.org/library/papers/22228214 | PubMed |
| 20 | 19479982 | Physiologically based predictions of the impact of inhibition of intestinal and hepatic metabolism on human pharmacokinetics of CYP3A substrates. | J Pharm Sci | 2010 | https://conductscience.org/library/papers/19479982 | PubMed |
Cited by287
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 463 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42974179 | A Dual Mechanism-Based Physiologically Based Pharmacokinetic Model for Predicting Mitoxantrone and Liposomal Mitoxantrone Disposition: Preclinical Validation in Rats and Human Extrapolation with Clinical Evaluation. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42974179 | PubMed |
| 42953428 | Advanced drug delivery and PBPK modelling as translational tools for precision therapies in juvenile idiopathic arthritis. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42953428 | PubMed |
| 42942786 | PBPK Modeling Investigation of IVIVE-Observed Pharmacokinetic Divergence for VU0467319: A Mechanistic Refinement Workflow for Low-Solubility Compounds. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/42942786 | PubMed |
| 42927046 | Hybrid Mechanistic-Neural Modeling of Concentration-Time Dynamics Generalizes Human Pharmacokinetics Prediction Across Unseen Chemical Space. | bioRxiv | 2026 | https://conductscience.org/library/papers/42927046 | PubMed |
| 42867201 | Overview of Regulatory Guidelines Related to Methods and Models for Small Populations. | Clin Pharmacol Ther | 2026 | https://conductscience.org/library/papers/42867201 | PubMed |
| 42761162 | Integration of microphysiological systems with computational and digital twin modeling for pharmaceutical development: a systematic review. | J Pharm Pharm Sci | 2026 | https://conductscience.org/library/papers/42761162 | PubMed |
| 42745804 | Physiologically-based pharmacokinetic model to predict loading dose polymyxin B exposure in critically ill patients with sepsis. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42745804 | PubMed |
| 42682178 | Physiologically Based Pharmacokinetic Modeling to Predict Human Starting Dose and Pharmacokinetics for Rocbrutinib. | Clin Transl Sci | 2026 | https://conductscience.org/library/papers/42682178 | PubMed |
| 42670843 | Gaps in AI-Driven Pharmacokinetic Property Prediction for Early Drug Development: A Scoping Review. | J Chem Inf Model | 2026 | https://conductscience.org/library/papers/42670843 | PubMed |
| 42654079 | Mechanism-Based Pharmacokinetic and Pharmacodynamic Modeling. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/42654079 | PubMed |
| 42622756 | Microplastics as carriers of environmental contaminants: Implications for human exposure, toxicokinetics, and health risk. | Environ Geochem Health | 2026 | https://conductscience.org/library/papers/42622756 | PubMed |
| 42618963 | Transitioning from Transcriptomics to Proteomics: Enhancing Mechanistic Accuracy in PBPK Modeling via Absolute Protein Abundances. | CPT Pharmacometrics Syst Pharmacol | 2026 | https://conductscience.org/library/papers/42618963 | PubMed |
| 42539599 | Physiologically based pharmacokinetic modeling of tafenoquine and evaluation of transporter-mediated drug-drug interactions. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42539599 | PubMed |
| 42535720 | From Small Data to Big Decisions: How Clinical Pharmacology Shapes Rare Disease Development. | J Clin Pharmacol | 2026 | https://conductscience.org/library/papers/42535720 | PubMed |
| 42529478 | Scientific Opinion on waiving of the dog studies in the regulatory process of agrochemicals approval. | EFSA J | 2026 | https://conductscience.org/library/papers/42529478 | PubMed |
| 42514902 | Beyond Body Weight: A Comprehensive Review of Allometric Scaling in Drug Development for Human Dose Predictions. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/42514902 | PubMed |
| 42495293 | Integrating Experimental Physicochemical Data with PBPK Modeling to Guide the Translational Development of the Antifungal 1,3,4-Oxadiazole Derivative LMM6. | ACS Omega | 2026 | https://conductscience.org/library/papers/42495293 | PubMed |
| 42435187 | Mathematical Modeling in Cancer Metabolism: Tools for Translational Applications in Metabolism-Based Therapy. | Adv Exp Med Biol | 2026 | https://conductscience.org/library/papers/42435187 | PubMed |
| 42400597 | Best Practices in Physiologically Based Pharmacokinetic (PBPK) Modeling. | CPT Pharmacometrics Syst Pharmacol | 2026 | https://conductscience.org/library/papers/42400597 | PubMed |
| 42398834 | New approach methodologies (NAMs) for preclinical and translational evaluation of mRNA-lipid nanoparticle (LNP) therapeutics. | J Control Release | 2026 | https://conductscience.org/library/papers/42398834 | PubMed |
Genes6
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ABCB1 | 5243 | PubTator's text mining | https://conductscience.org/library/genes/5243 | NCBI Gene |
| CYP2C8 | 1558 | PubTator's text mining | https://conductscience.org/library/genes/1558 | NCBI Gene |
| CYP3A4 | 1576 | PubTator's text mining | https://conductscience.org/library/genes/1576 | NCBI Gene |
| CYP4F3 | 4051 | PubTator's text mining | https://conductscience.org/library/genes/4051 | NCBI Gene |
| SLCO1A2 | 6579 | PubTator's text mining | https://conductscience.org/library/genes/6579 | NCBI Gene |
| SLCO1B1 | 10599 | PubTator's text mining | https://conductscience.org/library/genes/10599 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/23945604
GET https://conductscience.org/api/papers/v1/23945604/references?page=2